compaction; well before the fetus develops (Harvey and Kaye, Provision of the maternal factors, albumin and/or insulin , 1990 , 1991a , 1992a Mattson et al., 1988;  Heyner to embryos in vitro restores preimplantation morphological et al., 1989; Telford et al., 1990a,b; Rappolee et al., 1992 ; development and cell proliferation to that seen in vivo. The Smith et al., 1993) . From this stage, which marks the beginning hypothesis that the preimplantation effects of insulin or of the embryonic differentiation leading to blastocyst formation albumin would be reflected in increased fetal growth rate (Gardner and Johnson, 1975) , many parameters of embryonic was examined. Two-cell embryos were cultured 48-50 h in physiology may be regulated by exogenous insulin or IGF-I medium supplemented with 0.17 µmol/l, 15 µmol/l albumin (for reviews, see Schultz and Heyner, 1993 ; or 0.17 µmol/l insulin and the resultant blastocysts trans- Kaye and Harvey, 1995; . Human oocytes express ferred to pseudopregnant recipients. Fetal and placental insulin and IGF receptors (Lighten et al., 1997) , which respond mass and skeletal development were determined at E19 or to IGF-I (Lighten et al., 1998) . These hormonally induced E20 (day 19 or 20 of embryonic development). Preimplantamodifications to metabolism and cell physiology have the tion access to insulin or albumin increased fetal growth by net effects of increasing mitotic rate, cell proliferation and 4-6%. Combining insulin and albumin did not produce a morphogenesis. Preimplantation embryos do not synthesize further increment in fetal growth. The fetal growth achieved insulin or its mRNA (Telford et al., 1990a,b; ; by providing preimplantation access to insulin, albumin or Lighten et al., 1997) but have access to maternal insulin in vivo both was equivalent to that of in-vivo developed blastocysts.
via oviduct and uterine fluids (Heyner et al., 1989) . Thus The conclusions are that: (i) preimplantation access to in-vitro preimplantation embryos would be deprived of this maternal insulin and albumin is required for normal fetal maternal hormone. growth rates in the mouse and (ii) the increments in inner Morphological development and cell proliferation during cell mass cell number and metabolic rates induced by preimplantation embryogenesis are retarded in vitro when insulin (and possibly albumin) reflect a requirement for insulin is not present (Bowman and Mclaren, 1970 ; Gardner maternal growth factors during preimplantation stages to . Insulin increased the rate of compaction and optimize fetal development.
blastocyst formation in vitro and the resulting blastocysts Key words: fetus/growth/insulin/preimplantation embryo/protein contained about 25% more cells, all of which were located in the inner cell mass (Harvey and Kaye, 1990) . This suggests that the size of the pool of fetal progenitor cells in the mouse embryo is under control of maternal insulin. Since the Introduction proportion of cells in the inner cell mass is a determinant of fetal growth, it is likely that preimplantation access to maternal Key determinants of mammalian fetal growth include insulin, the insulin-like growth factors (IGF) and maternal nutrition.
insulin is required for optimal fetal growth. Maternal protein nutrition is another determinant of fetal Recent evidence suggests that preimplantation embryonic physiology also impacts on fetal growth. Although the trauma growth (Koshy et al., 1975) which also affects preimplantation development (Caro and Trounson, 1984 ; Gardner and Kaye, of isolation of a preimplantation embryo from the maternal milieu does not prevent implantation, subsequent fetal growth 1991; Lane and Gardner, 1994) . In vivo, maternal serum protein is taken up by the morulae and blastocysts (Glass, rate after implantation is affected (Bowman and McLaren, 1970; Harlow and Quinn, 1979; Lancaster et al., 1995; 1963) , via endocytosis and in vitro the exogenous albumin is metabolized in lysosomes (Pemble and Kaye, 1986; Dunglison Thompson et al., 1995; Holm et al., 1996) . The first differentiation of embryogenesis occurs during the preimplantation et al., 1995) . Endocytic rate increases in the absence of protein (Dunglison and Kaye, 1995) suggesting that metabolic demand phase in mammals and produces the inner cell mass, whose cells are progenitors of the fetus and the trophectoderm which regulates protein supply to the embryo through endocytosis. The importance of this maternal protein is emphasized by contributes only to placental tissues. This differentiation is fundamental to future development and may be disturbed by the observation that albumin increased cell proliferation and morphogenesis of preimplantation embryos in vitro (Gardner perturbation of the local environment. Thus disturbances to Three concentrations of albumin were used: 0, 0.17 µmol/l and 15 . This suggests that the maternal albumin µmol/l, but only two were tested in the ANOVA, because E20 fetal present in oviductal and uterine secretions is a natural componunits from cultures supplemented with 0.17 µmol/l albumin were not ent of the preimplantation milieux, required for natural develexamined (Table II) . These data were absorbed or described by opment.
modifying factors that precede them in the analysis (not shown). The Do the increased inner cell mass population, stimulated variation attributed to albumin was obtained from the interactions anabolism and developmental acceleration generated before between insulin and albumin and albumin and fetal stage (Table III) 
Results
Ryde, NSW, Australia) and immediately mated. Two-cell embryos (E2) were collected 48 h later in M2 medium (Fulton and Whittingham, Weight modifying factors not associated with culture 1978) and cultured for 2 days (Gardner and Kaye, 1991) . The culture A number of factors associated with embryo transfer which medium was based on BMOC2 (Brinster, 1963) and contained 0 or impact on fetal mass were first assessed for their possible 0.17 µmol/l insulin (Humulin-R ® ; a gift from Lilly Industries Pty.
contribution to the treatment effects observed in these studies. weight of E19 fetuses into which they developed. In naturally 100-102 h post-HCG) were transferred to day 3 pseudopregnant pregnant mice, 95 Ϯ 2% (n ϭ 9 mice) of implantation sites recipients. The fetus and its placenta were weighed individually at E19 or E20. The gross morphology and skeleton were examined after yielded fetuses. In contrast, only 66% of transferred embryos fixing and staining with alizarin red S (Humason, 1972) . The number developed into fetuses; 64 Ϯ 7% (n ϭ 7 mice) of in-vivo of stained sub-sacral (caudal) vertebrae, carpal and tarsal bones and developed blastocysts and 71 Ϯ 2% (n ϭ 28 mice) of cultured phalanges of the foreleg and hind leg was recorded (Rugh, 1968) . To blastocysts. Both of these implantation rates were less than randomize possible uterine horn and recipient variance, blastocysts for naturally pregnant mice (P Ͻ 0.001). In the cultured from different culture media were transferred to opposite uterine embryos, the recipient (P Ͻ 0.01), position in the horn horns and replicate treatments were placed in the contralateral horn (P Ͻ 0.01), uterine horn in which implanted (P Ͻ 0.05) and of a different recipient. Separate experiments assessed the contribution number in the horn (P Ͻ 0.05) were all significant sources of of the stage of maternal pseudopregnancy to fetal growth of freshly variance, in addition to the medium supplementation and fetal collected blastocysts (E4) transferred to day 3 or day 4 pseudopregnant age which were the primary targets of this study.
recipients.
Fetal age Model formulation and statistical analyses
Naturally, fetal mass increased approximately exponentially Eight factors known to influence weight (weight modifying factors) from E17 to E19, with about a 37% increase per day (doubling were selected from studies of mice (McLaren and Michie, 1960; Barr time: 3.7-1.6 days; Figure 1 ; Table I ). Embryos that were et al., 1970) and rats (Bruce and Norman, 1975) : the sex of the fetus (S); the uterine horn in which the fetus was found (H); the number cultured grew more slowly, gaining about 28% increase in of fetuses in the horn (nH); the number of fetuses in the litter (nL); fetal mass between E19 and E20. However by E20 all fetuses the position in the horn (P); the age of the fetus since fertilization from cultured embryos, irrespective of access to albumin or (A); the recipient effect (M) and the treatment (T). The equation insulin had reached a mass of 1.6 g (Table II ). This was greater describing the model is:
than the birth weight of naturally gestated embryos (1.542 Ϯ fetal unit weight ϭ weight ϩ mol/l ϩ S ϩ P ϩ H ϩ nL ϩ nH ϩ 0.014; n ϭ 129 pups, 8 litters) and also of E19 fetuses A ϩ T ϩ random error.
developing from in-vivo developed blastocysts directly transThe generalized linear interactive modelling system (GLIM; Nelder ferred into day 4 recipient uteri (Table I) . and Wedderburn, 1972) was used on the basis that modifying factors were linearly dependent. A nonorthogonal unbalanced analysis of Preimplantation access to albumin and insulin variance (ANOVA) was used to analyse the results and describe the Provision of 15 µmol/l albumin increased fetal growth by source of variation. In the analysis of the contribution of albumin to the variance in fetal mass (Table II) , one degree of freedom was lost.
6.5% (P Ͻ 0.0001) measured at E19 (Table II) . Insulin (0.17 µmol/l) was similarly beneficial at E19 (5.7% increase over 1 Mean mass Ϯ SEM g and the total number of E19 ϩ E20 fetuses (n);
unsupplemented medium, Table II; Figure 2 ; P Ͻ 0.0001). By those with the same superscript are significantly different a,b,c P Ͻ 0.001, E20 fetal masses for all groups were similar although the d,e P Ͻ 0.0001, t-test. E19 and E20 ϭ days 19 and 20 of embryonic development.
interaction factor, ageϫinsulin, was not significant (Table IV , P Ͼ 0.05) indicating that the primary factor insulin was effective at both fetal ages (P Ͻ 0.01) (Table II and IV) . required combination of the E19 and E20 data (Table III) . Provision of 0.17 µmol/l albumin alone caused a 6% reduction Insulin and albumin concentration in fetal mass (P Ͻ 0.05) from that achieved by blastocysts that had developed with no protein or insulin. In contrast, One conclusion from the data above (Table II) was that insulin was not serving in its endocrine signalling role but simply as providing 15 µmol/l albumin increased fetal mass by 3.8% (P Ͻ 0.05) and increasing the albumin concentration from a protein supplement, either osmotically or nutritionally as might be the case for albumin. To test this possibility, a small 0.17-15 µmol/l caused a 10.7% increase in fetal growth (P Ͻ 0.001) in the absence of insulin. If insulin was already analysis of the effects of treatment with 0.17 µmol/l albumin, equimolar to insulin was included, but because of the small present, adding 0.17 µmol/l albumin decreased fetal mass by 6.6% (P Ͻ 0.01). Raising the albumin still further to 15 µmol/l number of embryos in these two treatments, statistical analysis increased fetal growth by 7% (P Ͻ 0.05), but combining until E20 (Table II) . This fetal mass was greater than that of 15 µmol/l albumin with 0.17 µmol/l insulin was no more fetuses arising from direct blastocyst (E4) transfer to day 3 stimulatory than 0.17 µmol/l insulin alone.
pseudopregnant uteri (Table I , P Ͻ 0.01), E19 naturally Insulin increased fetal mass by 4.6% in the absence of gestated fetuses (Table I , P Ͻ 0.01) or birth weight (see above). protein (P Ͻ 0.001) and 4.1% in the presence of equimolar Thus the fetuses developing from blastocysts with access to protein, but this latter difference was not statistically significant insulin or 15 µmol/l albumin grew as rapidly as exactly (probably because of the low number of embryos involved; comparable direct transfer blastocysts. Provision of the missing Tables III and IV) . There was no added benefit of combining maternal factors, insulin and/or albumin had rescued the 0.17 µmol/l insulin with 15 µmol/l albumin; the combination embryos from the trauma of culture in simple medium in vitro. produced the same 4-5% increase as each supplement alone.
Supplementation with albumin or insulin did not affect the In summary, insulin at 0.17 µmol/l was as effective as 100 placental mass but the extra day of gestation caused a 19% times more albumin, causing a 4-6% increase in fetal mass decrease in placental weight, E19 (all treatments): 0.16 Ϯ (Figure 2 ), but 0.17 µmol/l albumin was inhibitory to fetal 0.011, n ϭ 222; E20 (all treatments): 0.13 Ϯ 0.008, n ϭ 58, growth. Insulin treatment stimulated fetal growth in the absence P Ͻ 0.01. of albumin and possibly in the presence of equimolar albumin, but was no more beneficial than the 100-fold higher concentraSkeletal development tion of albumin.
Although there was a correlation between the amount of Natural pregnancy versus embryo transfer, placental weight ossification of the skeleton and fetal mass for embryos which developed with 0 or 0.17 µmol/l albumin, this link disappeared Cultured blastocysts (E4) transferred to day 3 pseudopregnant when the embryos were provided with 15 µmol/l albumin, uteri reached a fetal mass of about 1.6 g if allowed to gestate which tended to reduce the amount of ossification, but not significantly (Table V) . Despite the apparent increased skeletal (Table V) . The forelimbs of a few of these fetuses
were extensively ossified, but there were also fetuses with mass proliferation and fetal growth, but not trophectoderm proliferation or placental growth, therefore fetal growth appears Discussion to relate to inner cell mass cell number or inner cell mass/ The results show that insulin and albumin, components of the trophectoderm cell number ratio and the rates of cell proliferamaternal preimplantation environment, affect subsequent fetal tion prior to implantation. Support for this proposal comes growth. Embryos that developed during the preimplantation from studies of blastocysts from experimentally diabetic mice, period without access to insulin or albumin displayed retarded which contained fewer cells and exhibited reduced metabolic fetal growth compared to parallel direct asynchronous transfer rate (Beebe and Kaye, 1991) . A smaller inner cell mass blastocysts. This fetal growth retardation induced by absence population has been proposed to cause reduced stem cell of maternal factors during preimplantation culture was compopulation leading to the failure of embryogenesis in parthenopensated by provision of the maternal proteins, insulin or genetic embryos (Kaufman et al., 1977 (Kaufman et al., , 1984 ). The present albumin or both during the preimplantation period. However, data suggest that reduction in inner cell mass number leads to if gestation was allowed to continue, the E20 fetuses were retarded fetal growth. All of the mammals which have been heavier than fetuses arising from direct transfer of in-vivo examined express the insulin receptor transcript by E3 at the developed blastocysts (E4) to day 4 pseudopregnant uteri latest, and in several the transcript is present in the oocyte (Table I , P Ͻ 0.01), E19 naturally gestated fetuses (Table I , ). Yet none expresses insulin, which is available P Ͻ 0.01) and birth weight (see above). The abnormal fetal through maternal secretion into the fluids surrounding the growth from these in-vitro developed blastocysts (E4) may embryo at this time (Heyner et al., 1989) . The expression of indicate that in mice parturition and fetal growth are affected the insulin receptor, but not its ligand, in preimplantation by the stage of uterine pregnancy, since the E20 fetuses were embryos of diverse species, implies a critical role for maternal collected from uteri that were at day 19 of pregnancy. This insulin in early embryonic development. abnormal growth beyond E19 may also be a reflection of the Insulin may act through the insulin receptor or the closely large calf/lamb syndrome frequently reported after preimplantarelated type I IGF receptor. Insulin is effective on blastocysts tion embryonic manipulation (Thompson et al., 1995;  Holm from about 0.3 pmol/l with an EC50 about 1 pmol/l (Harvey et al., 1996 , reviewed by Young et al., 1998 and Kaye, 1988 Kaye, , 1990 . However, insulin may also bind to, and activate, the blastocyst type I IGF receptor from Role of insulin concentrations of about 5 nmol/l and EC50 of about 50 nmol/l Provision of insulin to the preimplantation embryo enhanced Kaye, 1991b, 1992b) . Thus the fetal growth subsequent fetal growth rate. This acceleration of fetal growth is stimulus from 0.17 µmol/l insulin may have occurred through likely to arise from the increased mitotic rate and morphological binding to either or both of the key insulin binding receptors development of these blastocysts induced by insulin or albumin present on the preimplantation mouse embryo. Mice lacking (Gardner and Kaye, 1991) , because the increase in cells the insulin receptor die shortly after birth (Accili et al., 1996) . induced by insulin was solely allocated to the inner cell mass
Mann-Whitney U-test), but addition of albumin to insulin
Mice lacking the insulin receptor substrate 1 (IRS1) protein, substrate of the insulin and type 1 IGF receptor tyrosine (Harvey and Kaye, 1990 ). These inner cell mass cells are the kinases (Araki et al., 1994) (which is present in wild type Kaye, 1988) , endocytosis and lysosomal degradation of exoperi-implantation embryos; Puschek et al., 1998) survive and genous protein and inhibiting breakdown of endogenous protein are severely growth retarded (Tamemoto et al., 1994) . This is (Dunglison and Kaye, 1993; . Perhaps similar to humans lacking the insulin receptor (Taylor, 1992) . these anabolic changes have the same net effect on protein These observations support mediation of insulin's stimulus by nutrition or metabolism in the preimplantation embryo as the embryonic insulin receptor. However, type I IGF receptor providing moderate concentrations of albumin, both resulting deficient mice also display fetal growth retardation (Baker in optimal inner cell mass cell number and consequent fetal et al., 1991; Liu et al., 1991) so either or both receptors might growth rates. This aspect is relevant to human in-vitro fertilizacontribute to the fetal growth. Recently it has been suggested tion (IVF) procedures which are trending towards longer that insulin acts via embryonic type II IGF/mannose 6 phosculture with media containing pooled serum albumin fractions. phate receptors to regulate fetal growth in mice, on the basis These data suggest that concentration of albumin should be of double deletion of the insulin receptor and the type I IGF maintained at least at 15 µmol/l to optimize subsequent receptor. These mice are severely growth retarded at E13.5 fetal growth. and exhibit delayed skeletal development (Louvi et al., 1997) . It is difficult to isolate preimplantation requirements from Placental growth and trophectoderm those of later fetal development in these mutant mouse models.
Placental growth was not affected by preimplantation supply Interestingly the present studies support a particular requireof either insulin or albumin. Yet this tissue develops from the ment for insulin in skeletal development, similar to the gene trophectoderm, which like other cells of the blastocyst deletion model. The in-vitro approach using wild type embryos expresses insulin receptors. In addition to providing the transhas enabled restriction of the insulin deficiency to the preimcytotic pathway for insulin to reach the inner cell mass (Heyner plantation phase (E2-E4), avoiding perturbation of prior et al., 1989) , the trophectoderm participates in the overall gametogenesis and subsequent gestation in utero which may resetting of embryonic physiology induced by insulin through confound observations of genetically modified mice.
enhanced endocytic activity (Dunglison and Kaye, 1993 ; Insulin was active before compaction (E3) generating more undifferentiated cells with higher mitotic indices in uncom- and protein anabolism (Kaye et al., pacted morulae (Gardner and Kaye, 1991) . Albumin did not 1992). Thus the trophectoderm is important in the blastocyst's have this effect on proliferation of undifferentiated cells prior response to both insulin and albumin, by providing metabolic to compaction. Since provision of insulin and albumin to the pathways to support the development of the inner cell mass preimplantation embryo has the same effect on fetal growth, and therefore the fetus. it follows that the increased number of undifferentiated cells
The fetuses developing from direct synchronous transfer generated by insulin before compaction does not contribute to were of similar weight to those which gestated naturally, the fetal growth enhancement of insulin. Rather, the increase indicating that the traumas of anaesthesia and surgery do not in differentiated inner cells produced by insulin during E3-E4 impact on fetal growth as previously reported (Harlow and accelerates fetal growth supporting the conclusions above. Quinn, 1979) . Comparison of the natural fetuses with those arising from blastocysts (E4) transferred to day 3 uteri reveals Albumin the fetal growth retardation caused by asynchronous transfer Similar benefits to fetal growth arise from preimplantation possibly reflecting the maternal control of implantation embryonic access to 15 µmol/l albumin. This may not be (Psychoyos, 1973) . surprising since the albumin used was a relatively crude
The preimplantation effects of insulin that include accelerpreparation in which both negative (Caro and Trounson, 1984) ated morphological progression increase in the size of the and positive (Ueno et al., 1984; Kane, 1985) affectors of inner cell mass cell population and protein anabolism, optimize preimplantation development have been reported. There may blastocyst physiology for successful early implantation and be some mildly toxic component of the albumin fraction used, embryogenesis leading to accelerated fetal growth. Fetal growth since 0.17 µmol/l albumin inhibited fetal growth and both acceleration also arises from the increased protein nutrient concentrations inhibited the effects of insulin on skeletal supply provided by albumin, which produces similar effects development. However the beneficial effects of 15 µmol/l on preimplantation embryo cell proliferation. The demonstrated albumin may relate to protein nutrition (Koshy et al., 1975) .
roles of embryonic growth factors in control of invasive After compaction endocytosis is activated (Reeve, 1981) and proteolytic activity required for implantation (Harvey et al. , would provide significant amino acid nutrients by lysosomal 1995), likely to be produced in greater amount from larger degradation of maternal protein (Pemble and Kaye, 1986;  more advanced blastocysts developing in the presence of Kaye, 1993, 1995) . It is therefore probable that maternal insulin and albumin, support this hypothesis. Human the stimulation of preimplantation cell division and subsequent embryos express insulin and IGF-I receptors and respond to fetal growth caused by albumin arise from increased nutrient IGF-I similarly to mouse embryos; it is therefore likely that supply via endocytosis. Supporting this conclusion, supply of inclusion of the easily obtained alternate ligand insulin in free amino acids also increased the developmental potential media for blastocyst culture may lead to improved outcomes of blastocysts in vitro Gardner, 1994, 1998) .
in terms of fetal growth and subsequent morbidity for these Interestingly, insulin may produce a similar anabolic metabolic/ nutrient status by increasing protein synthesis (Harvey and procedures.
